PLS December Quarter FY26: Strong Operational Performance and Strategic Progress
PLS Group (ASX: PLS) delivered solid results in the December Quarter FY26, with 208kt of spodumene concentrate produced, maintaining strong operational efficiencies. Sales rose 8% to 232kt, driven by a 57% increase in realised prices, reaching US$1,161/t. The company’s cash margin from operations surged to AU$166 million, supported by higher pricing and effective cost control. Unit operating costs increased, reflecting lower production volumes and inventory adjustments.
PLS is positioning for further growth with the Ngungaju plant's potential restart and ongoing studies for the P2000 expansion, which could increase Pilgangoora's production capacity. The company’s focus on diversifying through chemicals and downstream partnerships, such as the joint venture with POSCO, reflects its strategy to capitalize on the growing global demand for lithium. The balance sheet remains robust, with a cash balance of AU$954 million, setting the stage for continued growth and value creation
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
PLS December Quarter FY26: Strong Operational Performance and Strategic Progress
PLS Group (ASX: PLS) delivered solid results in the December Quarter FY26, with 208kt of spodumene concentrate produced, maintaining strong operational efficiencies. Sales rose 8% to 232kt, driven by a 57% increase in realised prices, reaching US$1,161/t. The company’s cash margin from operations surged to AU$166 million, supported by higher pricing and effective cost control. Unit operating costs increased, reflecting lower production volumes and inventory adjustments.
PLS is positioning for further growth with the Ngungaju plant's potential restart and ongoing studies for the P2000 expansion, which could increase Pilgangoora's production capacity. The company’s focus on diversifying through chemicals and downstream partnerships, such as the joint venture with POSCO, reflects its strategy to capitalize on the growing global demand for lithium. The balance sheet remains robust, with a cash balance of AU$954 million, setting the stage for continued growth and value creation
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au